Literature DB >> 21990131

Adrenal function in Smith-Lemli-Opitz syndrome.

Simona E Bianconi1, Sandra K Conley, Meg F Keil, Ninet Sinaii, Kristina I Rother, Forbes D Porter, Constantine A Stratakis.   

Abstract

Smith-Lemli-Opitz syndrome (SLOS) is a multiple malformation syndrome due to mutations of the 7-dehydrocholesterol reductase gene (DHCR7), which leads to a deficiency of cholesterol synthesis and an accumulation of 7-dehydrocholesterol. The SLOS clinical spectrum ranges from multiple major malformations to a mild phenotype with minor anomalies and intellectual disability. Several children with SLOS and adrenal insufficiency have been described. We performed ovine corticotropin (oCRH) testing in 35 SLOS patients and 16 age- and gender-matched controls. We reviewed prior adrenocorticotropin (ACTH) stimulation tests of our SLOS patients (19 of 35 available) and reviewed results of ACTH stimulation tests from 10 additional SLOS patients. Results from oCRH testing showed that patients with SLOS had significantly higher ACTH baseline values than healthy controls (24.8 ± 15.3 pg/ml vs. 17.8 ± 7.5 pg/ml, P = 0.034). However, no statistically significant differences were noted for peak ACTH values (74.4 ± 35.0 pg/ml vs. 64.0 ± 24.9 pg/ml, P = 0.303) and for baseline (14.2 ± 7.8 mcg/dl vs. 14.2 ± 6.3 mcg/dl, P = 0.992) and peak cortisol values (28.2 ± 7.9 mcg/dl vs. 24.8 ± 8.1 mcg/dl, P = 0.156). The area-under-the-curve (AUC) was not significantly different in SLOS patients compared to controls for both ACTH (250.1 ± 118.7 pg/ml vs. 195.3 ± 96.6 pg/ml, P = 0.121) as well as cortisol secretion (83.1 ± 26.1 mcg/dl vs. 77.8 ± 25.9 mcg/dl, P = 0.499). ACTH stimulation test results were normal in 28 of 29 tests. The individual with the abnormal test results had subsequent normal oCRH tests. The slightly increased baseline ACTH level seen during oCRH testing may be due to compensated adrenocortical insufficiency. However, we were able to show that our patients with SLOS had an adequate glucocorticoid response, and thus, in mild to moderate cases of SLOS stress steroid coverage may not be warranted. Published 2011 Wiley Periodicals, Inc. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21990131      PMCID: PMC3488380          DOI: 10.1002/ajmg.a.34271

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  44 in total

1.  Carrier frequency of the RSH/Smith-Lemli-Opitz IVS8-1G>C mutation in African Americans.

Authors:  Brooke S Wright; Ngozi A Nwokoro; Christopher A Wassif; Forbes D Porter; John S Waye; Barry Eng; Małgorzata J M Nowaczyk
Journal:  Am J Med Genet A       Date:  2003-07-01       Impact factor: 2.802

2.  Identification of 7(8) and 8(9) unsaturated adrenal steroid metabolites produced by patients with 7-dehydrosterol-delta7-reductase deficiency (Smith-Lemli-Opitz syndrome).

Authors:  Cedric Shackleton; Esther Roitman; Li Wei Guo; William K Wilson; Forbes D Porter
Journal:  J Steroid Biochem Mol Biol       Date:  2002-10       Impact factor: 4.292

Review 3.  The Smith-Lemli-Opitz syndrome.

Authors:  R I Kelley; R C Hennekam
Journal:  J Med Genet       Date:  2000-05       Impact factor: 6.318

4.  Adrenal insufficiency and hypertension in a newborn infant with Smith-Lemli-Opitz syndrome.

Authors:  M J Nowaczyk; V M Siu; P A Krakowiak; F D Porter
Journal:  Am J Med Genet       Date:  2001-10-15

5.  Comparison of the liquid-ordered bilayer phases containing cholesterol or 7-dehydrocholesterol in modeling Smith-Lemli-Opitz syndrome.

Authors:  Galya Staneva; Claude Chachaty; Claude Wolf; Peter J Quinn
Journal:  J Lipid Res       Date:  2010-02-10       Impact factor: 5.922

6.  Behavior phenotype in the RSH/Smith-Lemli-Opitz syndrome.

Authors:  E Tierney; N A Nwokoro; F D Porter; L S Freund; J K Ghuman; R I Kelley
Journal:  Am J Med Genet       Date:  2001-01-15

7.  Adrenal insufficiency and abnormal genitalia in a 46XX female with Smith-Lemli-Opitz syndrome.

Authors:  W Chemaitilly; A Goldenberg; G Baujat; E Thibaud; V Cormier-Daire; V Abadie
Journal:  Horm Res       Date:  2003

8.  Alteration of retinal rod outer segment membrane fluidity in a rat model of Smith-Lemli-Opitz syndrome.

Authors:  Kathleen Boesze-Battaglia; Monika Damek-Poprawa; Drake C Mitchell; Laura Greeley; Richard S Brush; Robert E Anderson; Michael J Richards; Steven J Fliesler
Journal:  J Lipid Res       Date:  2008-03-14       Impact factor: 5.922

9.  Novel mutation in the Delta-sterol reductase gene in three Lebanese sibs with Smith-Lemli-Opitz (RSH) syndrome.

Authors:  Marjan M Nezarati; Judith Loeffler; Grace Yoon; Linda MacLaren; Ernest Fung; Floyd Snyder; Gerd Utermann; Gail E Graham
Journal:  Am J Med Genet       Date:  2002-06-15

10.  A defective response to Hedgehog signaling in disorders of cholesterol biosynthesis.

Authors:  Michael K Cooper; Christopher A Wassif; Patrycja A Krakowiak; Jussi Taipale; Ruoyu Gong; Richard I Kelley; Forbes D Porter; Philip A Beachy
Journal:  Nat Genet       Date:  2003-03-24       Impact factor: 38.330

View more
  5 in total

1.  Pulmonary vein stenosis in patients with Smith-Lemli-Opitz syndrome.

Authors:  Aaron R Prosnitz; Jane Leopold; Mira Irons; Kathy Jenkins; Amy E Roberts
Journal:  Congenit Heart Dis       Date:  2017-07-18       Impact factor: 2.007

2.  Statins for Smith-Lemli-Opitz syndrome.

Authors:  Rami A Ballout; Simona Bianconi; Alicia Livinski; Yi-Ping Fu; Alan T Remaley; Forbes D Porter
Journal:  Cochrane Database Syst Rev       Date:  2020

Review 3.  Treatment of Smith-Lemli-Opitz syndrome and other sterol disorders.

Authors:  Melissa D Svoboda; Jill M Christie; Yasemen Eroglu; Kurt A Freeman; Robert D Steiner
Journal:  Am J Med Genet C Semin Med Genet       Date:  2012-10-05       Impact factor: 3.908

4.  Pathogenesis, Epidemiology, Diagnosis and Clinical Aspects of Smith-Lemli-Opitz Syndrome.

Authors:  Simona E Bianconi; Joanna L Cross; Christopher A Wassif; Forbes D Porter
Journal:  Expert Opin Orphan Drugs       Date:  2015-03       Impact factor: 0.694

5.  Smith-Lemli-Opitz syndrome presenting as acute adrenal crisis in a child: a case report.

Authors:  Chamara Jayamanne; Sajith Sandamal; Kasun Jayasundara; Mayoorathy Saranavabavananthan; Sachith Mettananda
Journal:  J Med Case Rep       Date:  2018-08-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.